InvestorsObserver
×
News Home

Where Does AC Immune SA (ACIU) Stock Fall in the Biotechnology Field After It Is Lower By -0.41% This Week?

Wednesday, November 10, 2021 11:24 AM | InvestorsObserver Analysts

Mentioned in this article

Where Does AC Immune SA (ACIU) Stock Fall in the Biotechnology Field After It Is Lower By -0.41% This Week?

AC Immune SA (ACIU) is near the top in its industry group according to InvestorsObserver. ACIU gets an overall rating of 62. That means it scores higher than 62 percent of stocks. AC Immune SA gets a 93 rank in the Biotechnology industry. Biotechnology is number 87 out of 148 industries.

Overall Score - 62
ACIU has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on ACIU!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 62 would rank higher than 62 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With AC Immune SA Stock Today?

AC Immune SA (ACIU) stock is trading at $7.21 as of 11:23 AM on Wednesday, Nov 10, a decline of -$0.30, or -5.95% from the previous closing price of $7.56. The stock has traded between $6.87 and $7.84 so far today. Volume today is below average. So far 167,157 shares have traded compared to average volume of 456,299 shares. Click Here to get the full Stock Report for AC Immune SA stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App